Continuing Access to In-Home IVIG Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jul 29, 2020)
Continuing Access to In-Home IVIG Act
This bill extends the Medicare Intravenous Immune Globulin (IVIG) Demonstration for an additional two years and expands the maximum number of participating beneficiaries from 4,000 to 6,500. The program provides bundled payments for items and services that are necessary for in-home IVIG administration for certain beneficiaries with primary immune deficiency disease.
What just happenedJul 29, 2020
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJul 29, 2020
- Jul 29, 2020Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jul 29, 2020IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Jul 29, 2020IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jul 29, 2020IntroReferralIntro-H
Introduced in House
- Jul 29, 2020IntroReferral1000
Introduced in House